These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28249644)

  • 1. Lymph node characteristics for predicting locoregional recurrence of papillary thyroid cancer in adolescents and young adults.
    Sun Y; Liu X; Ouyang W; Feng H; Wu J; Chen P; Wang J
    Oral Oncol; 2017 Mar; 66():22-27. PubMed ID: 28249644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
    Randolph GW; Duh QY; Heller KS; LiVolsi VA; Mandel SJ; Steward DL; Tufano RP; Tuttle RM;
    Thyroid; 2012 Nov; 22(11):1144-52. PubMed ID: 23083442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.
    Jianyong L; Jinjing Z; Zhihui L; Tao W; Rixiang G; Jingqiang Z
    Thyroid; 2018 Mar; 28(3):301-310. PubMed ID: 29439612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
    Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
    World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
    Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
    Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Lymph Node Metastases After Thyroidectomy for Papillary Thyroid Carcinoma Usually Remain Stable for Years.
    Tomoda C; Sugino K; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Ito K
    Thyroid; 2016 Dec; 26(12):1706-1711. PubMed ID: 27616725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.
    Wang LY; Palmer FL; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
    Ann Surg Oncol; 2015 Oct; 22(11):3530-6. PubMed ID: 25665952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY; Lee TH; Ku YH; Kim HI; Lee GH; Kim MJ
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients.
    Suh YJ; Kwon H; Kim SJ; Choi JY; Lee KE; Park YJ; Park DJ; Youn YK
    Ann Surg Oncol; 2015 Oct; 22(11):3543-9. PubMed ID: 25743326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIZE OF THE LARGEST METASTATIC FOCUS TO THE LYMPH NODE IS ASSOCIATED WITH INCOMPLETE RESPONSE OF PN1 PAPILLARY THYROID CARCINOMA.
    Deng Y; Zhu G; Ouyang W; Pan L; Feng H; Wu J; Chen P; Wang J; Xian J
    Endocr Pract; 2019 Sep; 25(9):887-898. PubMed ID: 31170371
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
    Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
    Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
    Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.